The Latest in Rheumatoid Arthritis

Rheumatology News

Poor Use of ICD-10 Rheumatology Codes Suggests New Approach Needed for ICD-11 Adoption

April 26, 2024

Rheumatology News

The Patient Knows Best: Integrating Patient-Reported Outcomes in RA Practice and Research

April 22, 2024

Rheumatology News

Mining EHRs with AI to Predict RA Outcomes: Coming to You Soon?

April 19, 2024

Rheumatology News

Shared Rheumatology-Primary Care Telehealth Model Brings Services to Rural Areas

April 18, 2024

Rheumatology News

Could Modifying Gut Microbiota Enhance Response to Methotrexate in RA?

April 17, 2024

Rheumatology News

RA Flare Risk Rises Following DMARD Taper to Discontinuation With Conventional Synthetics or TNF Inhibitors

April 16, 2024

Rheumatology News

High Infection Risk in Rheumatoid Arthritis–Associated Interstitial Lung Disease

April 12, 2024

Rheumatology News

Congress Directly Provides $10 Million for Arthritis Research for First Time

April 8, 2024

Rheumatology News

Tuberculosis Screening Gaps Persist in New DMARD Users

April 3, 2024

Rheumatology News

Autoimmunity’s Female Bias and the Mysteries of Xist

April 2, 2024

Rheumatology News

No Excess Cancer Risk Seen with Non-TNF Inhibitor Biologics in RA

March 19, 2024

Rheumatology News

AI’s Future and Current Role in Rheumatology

March 14, 2024

Rheumatology News

RA Outcomes Worsened by Depression and Anxiety, Signaling Need for Multidisciplinary Action

March 13, 2024

Rheumatology News

Second FDA-Approved Tocilizumab Biosimilar Has Intravenous, Subcutaneous Formulations

March 8, 2024

Rheumatology News

Leflunomide: A Fresh Look at an Old Drug

March 8, 2024